Iyuda Therapeutics, Inc.

Amendment

CIK: 0001993594·Biotechnology·DELAWARE·Filed: Jun 6, 2025

Total Offering

$1,312,337

Amount Sold

$1,312,337

Investors

3

First Sale

Oct 1, 2024

Offering Details

Type: Equity
Exemptions: Rule 506(b)
Entity Type: Corporation
Non-Accredited Investors: No

Related Persons

Name	Role
Robert Tennant	Related Person
Ephraim Fuchs	Related Person

Company

Iyuda Therapeutics, Inc.

3217 Hunting Tweed Drive

Owings Mills, MD, 21117

202-913-8697

SEC Filing

0000905148-25-002036

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.